Clinical Trial Update: Vitamin B12a Vasoplegic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Vitamin B12a in vasoplegic syndrome; study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasoplegic Syndrome

Drugs mentioned

• Vitamin B12a

Snippet

Sponsor: Mayo Clinic | Conditions: Vasoplegic Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2023-05-10